RxDoctor Payments Data

Denny le, DPM

Foot & Ankle Surgery · Portland, ORNPI 1285977470

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,452 of the $9,014 with a category attached, or 60.5%. 40 manufacturers reported payments, led by Steelhead Surgical Inc at 38.1% of the total. Reporting peaked in 2020 at $2,205 and has fallen 83.8% since, to $358 in 2025.

$9,014in general payments, 2019–2025

Across 159 payments — averaging $56.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Steelhead Surgical Inc$3K
  • Johnson & Johnson$850
  • Smith+Nephew$802
  • Stryker$773
  • Arthrex$538
  • Zimmer Biomet$485
  • plus $2K from 34 others

What the payments were for

  • Travel & lodging$4645%
  • Food & beverage$5,45260%
  • Education$3,09834%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,014 in reported general payments places this provider in the 80th percentile of 113 foot & ankle surgery providers in Oregon.

See all foot & ankle surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$129,726
Medicare patients
368
Services billed
1,764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole26$641
Naproxen83$550
Doxycycline Monohydrate52$500
Clindamycin Hcl20$186

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →